Medication info
Viteb Tablet 10/20 Milligrams

Viteb Tablet 10/20 Milligrams

Prescription medicationTabletOral
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›20mg / 1 tablet
Manufacturer / importer
Genewon Science Co., Ltd.
Appearance
White to off-white, bi-convex, rectangular tablets
Packaging
30 tablets (10 tablets/PTP*3)
Approval status
Active

MFDS item code 201601004 · Approved 2016.02.23 · Insurance code 671704950

Summary

Main use
Improves primary and homozygous familial hypercholesterolemia and mixed hyperlipidemia
Who takes it
Adults
Adult dose
Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Administer this medicine once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range is 10/10mg~10/40mg per day. The usual recommended initial dose is 10/20mg per day. Patients who require less LDL cholesterol reduction may start at 10/10mg per day. After starting this medicine or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of at least 4 weeks. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see Precautions for Use, 1. Warnings). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This medicine is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is required for patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see Precautions for Use, 5. General Precautions, Patients with Abnormal Liver Function). Administration to patients with renal impairment and chronic kidney disease No dose adjustment is required for patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. Use higher doses in these patients with caution and monitor them closely (see Precautions for Use, 5. General Precautions). Administration to elderly patients No dose adjustment is required in elderly patients. Concomitant administration with other medicines (See Precautions for Use, 6. Interactions.) Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.

Ingredients

Manufacturer
Genewon Science Co., Ltd.

Efficacy & effects

Improves primary and homozygous familial hypercholesterolemia and mixed hyperlipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • increased risk of atherosclerotic vascular disease due to hypercholesterolemia
  • dyslipidemia
  • diabetes
  • hypothyroidism
  • obstructive liver disease
  • chronic renal failure
View approved original text

This medicine is used in conjunction with diet for patients with primary hypercholesterolemia and mixed hyperlipidemia to help lower total cholesterol, LDL cholesterol, ApoB protein, and triglyceride levels in the blood, while helping to increase levels of HDL cholesterol, which is known as good cholesterol. Additionally, for patients with homozygous familial hypercholesterolemia, it can be used as an adjunct or alone to effectively manage cholesterol levels. This medicine plays an important role in reducing the risk of atherosclerotic vascular disease caused by hypercholesterolemia and should be used alongside appropriate dietary modification and other non-drug therapies. Furthermore, it is important to identify and treat secondary causes first, and regular lipid testing is necessary during the treatment process. Through comprehensive management, it effectively improves lipid levels in the blood.

How to take

Adult dose

Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Administer this medicine once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range is 10/10mg~10/40mg per day. The usual recommended initial dose is 10/20mg per day. Patients who require less LDL cholesterol reduction may start at 10/10mg per day. After starting this medicine or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of at least 4 weeks. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see Precautions for Use, 1. Warnings). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This medicine is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is required for patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see Precautions for Use, 5. General Precautions, Patients with Abnormal Liver Function). Administration to patients with renal impairment and chronic kidney disease No dose adjustment is required for patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. Use higher doses in these patients with caution and monitor them closely (see Precautions for Use, 5. General Precautions). Administration to elderly patients No dose adjustment is required in elderly patients. Concomitant administration with other medicines (See Precautions for Use, 6. Interactions.) Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.

Precautions

This medication is used to lower cholesterol levels in the blood. Symptoms such as muscle pain or weakness may occur while taking this medication, so caution is necessary. If unexplained muscle aches or weakness occur, you should notify your doctor immediately. This medication should not be used in patients with impaired liver function, active liver disease, and in pregnant or nursing women. Additionally, co-administration with certain medications may increase the risk of muscle damage, so it is essential to inform your doctor or pharmacist if you are taking other medications. Co-administering this medication with strong CYP3A4 inhibitors, gemfibrozil, cyclosporine, danazol, and some calcium channel blockers may increase the risk of adverse effects, so such co-administration may be contraindicated or require dose adjustment. Grapefruit juice may also increase the blood concentration of this medication, so it is advisable to avoid consuming it in large amounts. Patients who take this medication are advised to have regular blood sugar tests as it may increase blood sugar levels, especially in elderly patients or those at risk for diabetes. Additionally, regular tests of liver function and muscle-related tests while taking this medication are recommended. Patients taking this medication should always inform healthcare providers of this when being prescribed new medications and should consult medical personnel immediately if they experience any unusual symptoms. In the case of overdose, there is no specific antidote, so you should seek immediate medical attention.

Side effects

Myopathy, rhabdomyolysis, elevated creatine kinase, headache, diarrhea, influenza, upper respiratory infection, myalgia, limb pain, fatigue, abdominal pain, viral infection, pharyngitis, sinusitis, arthralgia, low back pain, cough, anaphylaxis, urticaria, rash, angioedema, elevated liver aminotransferase levels, hepatitis, thrombocytopenia, nausea, pancreatitis, dizziness, paresthesia, depression, cholelithiasis, cholecystitis, mucous membrane syndrome, toxic epidermal necrolysis, eosinophilia, systemic symptoms associated drug reactions, erythema multiforme, myasthenia, cataracts, constipation, dyspepsia, flatulence, nausea, eczema, pruritus, rash, muscle cramps, specific cranial nerve dysfunction, oculomotor dysfunction, facial weakness, tremor, peripheral neuropathy, peripheral nerve paralysis, mental disorders, anxiety, sleep disorders, memory impairment, forgetfulness, amnesia, memory dysfunction, confusion, interstitial lung disease, lupus erythematosus-like syndrome, polymyositis, dermatomyositis, vasculitis, purpura, leukopenia, hemolytic anemia, positive antinuclear antibody, elevated erythrocyte sedimentation rate, arthritis, fever, chills, flushing, fatigue, dyspnea, cholestatic jaundice, liver fat changes, cirrhosis, acute hepatic necrosis, liver cancer, liver failure, anorexia, vomiting, alopecia, various skin changes, lichenoid drug eruption, gynecomastia, decreased libido, sexual dysfunction, ocular muscle paralysis, anemia, elevated aminotransferase levels, ALP elevation, elevated ɤ-GT, increased bilirubin levels, thyroid dysfunction, increased HbA1c, elevated fasting blood glucose levels, edema, thirst, facial swelling, syncope, insomnia, gastritis, atrophic gastritis, mucus stools, irritable bowel syndrome, sore throat, nocturia, hematuria, weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it must be stored in a tightly closed container. It is recommended to maintain a storage temperature between 1 degree and 30 degrees Celsius. This will help preserve the effectiveness of the medication for a long time.

Appearance and packaging

Appearance

White to off-white, bi-convex, rectangular tablets

Package unit

30 tablets (10 tablets/PTP*3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.